194 related articles for article (PubMed ID: 1759514)
1. [The possibility of creating a vaccinal strain of Brucella abortus 19-BA with multiple antibiotic resistance].
Gorelov VN; Gubina EA; Grekova NA; Skavronskaia AG
Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):2-4. PubMed ID: 1759514
[TBL] [Abstract][Full Text] [Related]
2. Brucella abortus strain RB51 leucine auxotroph as an environmentally safe vaccine for plasmid maintenance and antigen overexpression.
Rajasekaran P; Seleem MN; Contreras A; Purwantini E; Schurig GG; Sriranganathan N; Boyle SM
Appl Environ Microbiol; 2008 Nov; 74(22):7051-5. PubMed ID: 18836016
[TBL] [Abstract][Full Text] [Related]
3. DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate.
Yang X; Thornburg T; Walters N; Pascual DW
Vaccine; 2010 Jan; 28(4):1069-74. PubMed ID: 19914192
[TBL] [Abstract][Full Text] [Related]
4. Identification of Brucella abortus B19 vaccine strain by the detection of DNA polymorphism at the ery locus.
Sangari FJ; Agüero J
Vaccine; 1994 Apr; 12(5):435-8. PubMed ID: 7912870
[TBL] [Abstract][Full Text] [Related]
5. Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice.
Tibor A; Jacques I; Guilloteau L; Verger JM; Grayon M; Wansard V; Letesson JJ
Infect Immun; 1998 Nov; 66(11):5561-4. PubMed ID: 9784574
[TBL] [Abstract][Full Text] [Related]
6. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
Bolpe J; de Lapenta DF; García-Carrillo C
Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the immunobiological properties of live brucellosis vaccines.
Salmakov KM; Fomin AM; Plotnikova EM; Safina GM; Galimova GM; Salmakova AV; Ivanov AV; Panin AN; Sklyarov OD; Shumilov KV; Klimanov AI
Vaccine; 2010 Oct; 28 Suppl 5():F35-40. PubMed ID: 20362201
[TBL] [Abstract][Full Text] [Related]
8. Brucella abortusΔcydCΔcydD and ΔcydCΔpurD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus.
Truong QL; Cho Y; Park S; Kim K; Hahn TW
Vaccine; 2016 Jan; 34(2):237-244. PubMed ID: 26616550
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic analysis of Brucella abortus vaccine strain 104M reveals a set of candidate genes associated with its virulence attenuation.
Yu D; Hui Y; Zai X; Xu J; Liang L; Wang B; Yue J; Li S
Virulence; 2015; 6(8):745-54. PubMed ID: 26039674
[TBL] [Abstract][Full Text] [Related]
10. Resistance of normal or immunized guinea pigs against a subcutaneous challenge of Brucella abortus.
Pardon P; Marly J
Ann Rech Vet; 1978; 9(3):419-25. PubMed ID: 107845
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
[TBL] [Abstract][Full Text] [Related]
12. Immunization of guinea pigs with Salmonella delivered anti-Brucella formulation reduces organs bacterial load and mitigates histopathological consequences of Brucella abortus 544 challenge.
Lalsiamthara J; Lee JH
Vet Immunol Immunopathol; 2018 Jan; 195():40-45. PubMed ID: 29249316
[TBL] [Abstract][Full Text] [Related]
13. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.
Lalsiamthara J; Gogia N; Goswami TK; Singh RK; Chaudhuri P
Vaccine; 2015 May; 33(22):2577-83. PubMed ID: 25869887
[TBL] [Abstract][Full Text] [Related]
14. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
15. Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.
de Souza Filho JA; de Paulo Martins V; Campos PC; Alves-Silva J; Santos NV; de Oliveira FS; Menezes GB; Azevedo V; Cravero SL; Oliveira SC
Infect Immun; 2015 Apr; 83(4):1458-64. PubMed ID: 25644010
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel drug targets for humans and potential vaccine targets for cattle by subtractive genomic analysis of Brucella abortus strain 2308.
Mahmud A; Khan MT; Iqbal A
Microb Pathog; 2019 Dec; 137():103731. PubMed ID: 31509762
[TBL] [Abstract][Full Text] [Related]
17. The NOD-
Khalaf OH; Chaki SP; Garcia-Gonzalez DG; Ficht TA; Arenas-Gamboa AM
Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30936160
[TBL] [Abstract][Full Text] [Related]
18. Immunization with recombinant GntR plasmid confers protection against Brucella challenge in BALB/c mice.
Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Han J; Zhang J
Microb Pathog; 2017 Oct; 111():357-361. PubMed ID: 28916314
[TBL] [Abstract][Full Text] [Related]
19. The immune response of guinea pigs and buffalo calves to the locally prepared Brucella abortus strain 19 vaccine.
Jamal SM; Afzal M; Ahmed S
Rev Sci Tech; 2003 Dec; 22(3):893-7. PubMed ID: 15005547
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Brucella abortus vaccine strain A19 reveals its potential mechanism of attenuated virulence.
Cheng Z; Li Z; Yin Y; Lian Z; Abdelgawad HA; Hu H; Guan X; Zuo D; Cai Y; Ding C; Wang S; Li T; Qi J; Tian M; Yu S
Vet Microbiol; 2021 Mar; 254():109007. PubMed ID: 33582483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
